Volta

Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2

Unknown authors · 2023
hash_id: f47658330ccf50a0d7f15f4a5162899d38a7dbca704fcae9069bd01368c7cb6e · DOI: 10.1016/j.cmi.2023.04.019

SCOPE: Since the onset of COVID-19, several assays have been deployed for the diagnosis of SARS-CoV-2. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first set of guidelines on SARS-CoV-2 in vitro diagnosis in February 2022. Because the COVID-19 landscape is rapidly evolving, the relevant ESCMID guidelines panel releases an update of the previously published recommendations on diagnostic testing for SARS-CoV-2. This update aims to delineate the best diagnostic approach for SARS-CoV-2 in different populations based on current evidence. METHODS: An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small group was established, half appointed by the chair, and the remaining selected with an open call. The panel met virtually once …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (3)

Current Perspectives on Antigen Testing in Respiratory Infections secondary
Clinical accuracy of instrument-based SARS-CoV-2 antigen diagnostic tests: a sy… secondary
Clinical accuracy of instrument-based SARS-CoV-2 antigen diagnostic tests: A sy… secondary

Cited by (2)

SARS-CoV-2 rapid antigen testing for departing passengers at Vancouver Internat… primary
Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An up… secondary